{
    "publish_date": "2024-04-19",
    "youtube_url": "https://youtube.com/watch?v=Mn07xCOfyzw",
    "thumbnail_url": "https://i.ytimg.com/vi/Mn07xCOfyzw/sddefault.jpg",
    "interviewer": "Evening Standard",
    "interviewee": "Ben Lamm",
    "insights": "## 3 Most Interesting Insights from the Audio:\n\n**1. Mammoth Calves by 2028:** The company is aiming to produce the first mammoth calves by 2028. They seem confident about this timeline, especially with their recent success in creating induced pluripotent stem cells for elephants. This is a significant step towards de-extinction and could have major implications for conservation and scientific research.\n\n**2. Mammoths May Not Be First:** While mammoths are the primary focus, the speaker hints that they might not be the first extinct species to be brought back.  The company has not made any specific commitments yet, suggesting they are exploring possibilities with other extinct animals. This opens doors to exciting possibilities and raises questions about which species they might target next.\n\n**3. Underpromise and Overdeliver:** The company's approach appears to be \"underpromise and overdeliver.\" They acknowledge the difficulty of their work and avoid setting overly ambitious timelines or expectations. This cautious approach demonstrates a commitment to scientific rigor and transparency, which is crucial for maintaining public trust and support for their endeavors. \n"
}